MedBridge Ranked on the Inc. 5000 List of the Fastest-Growing Private Companies for Sixth Year
SEATTLE, October 4, 2022 (Newswire.com) - MedBridge today announced that it has been named to this year's Inc. 5000 list of fastest-growing private companies. The industry-leading provider of patient engagement and professional development solutions enables healthcare organizations to effectively train and develop providers while supplying clinicians with tools to give personalized, attentive care at lower costs.
"At MedBridge, our mission is to help healthcare organizations of every size engage and empower their clinicians with the tools they need to effectively deliver the highest-quality care," said Leigh Wager, VP of Strategic Solutions at MedBridge. "We are honored to be recognized for the sixth year, and are excited to continue finding innovative ways to elevate healthcare."
MedBridge's continued growth has been bolstered by several new innovations this year, including the Skills and Competency Manager, Remote Therapeutic Monitoring Solution, and Hospice Solution. Partnering with over 2,500 healthcare organizations across the continuum of care, MedBridge combines evidence-based staff and patient education, digital engagement, and virtual patient care tools to help organizations empower clinicians and their patients by creating clinical pathways that better engage patients, improve operational efficiency, reduce readmissions, and lower cost per episode.
Over the past year, MedBridge has received a number of additional accolades and recognitions, including a 2022 MedTech Breakthrough Award, 2021 Puget Sound Business Journal Middle Market Fast 50, and the 2021 Inc. 5000 List of Fastest-Growing Private Companies.
The Inc. 5000 list recognizes MedBridge as one of the nation's most successful private companies based on its robust revenue growth over a three-year period. The list provides a rich picture of the U.S. entrepreneurial landscape and captures a broad spectrum of success and innovation across multiple industries.
Source: MedBridge
